Heart Disease in Women

N. Nanda, N. Keser
{"title":"Heart Disease in Women","authors":"N. Nanda, N. Keser","doi":"10.5005/jp/books/12562","DOIUrl":null,"url":null,"abstract":"e5 Heart disease is the leading cause of death among women. In comparison with men, women have greater cardiovascular mortality, report more morbidity, and have greater reductions in quality of life. Furthermore, sex disparities in cardiovascular health exist among women of all ages, socioeconomic backgrounds, and racial subgroups, which likely reflect both lingering diagnostic and treatment disparities, and underlying biological sex differences, as well. For example, there is a largely female predominance of stress-induced (Takotsubo) cardiomyopathy after menopause, a greater occurrence of heart failure with preserved ejection fraction, particularly in elderly women, and a higher incidence of rheumatic mitral stenosis among women in developing countries. In addition, after 55 years of age, hypertension is more prevalent in women than in men, particularly in black women. Clinical outcomes also differ by sex. Women with atrial fibrillation have a higher risk of thromboembolic events in comparison with men, and, among individuals younger than 55 years of age, the rate of acute myocardial infarction in the past decade has declined in men, but not in women. As the importance and impact of cardiovascular disease in women is increasingly recognized, we are learning how heart disease is distinct between the sexes, both in its pathophysiology and in our ability to diagnose and treat women. To better understand and appreciate sex differences in cardiovascular disease, there needs to be a compilation of current knowledge and an accessible tool that increases awareness of these differences. Heart Disease in Women, by Drs Navin Nanda and Nurgul Keser, is that clinical tool and an excellent resource for all providers of women’s health. Heart Disease in Women brings greater awareness to sex-specific differences in heart disease and emphasizes the unique features of cardiovascular disease in women. The book consists of 34 chapters organized into 8 sections covering prevention and risk factors, coronary heart disease, noninvasive testing, heart failure and cardiomyopathies, arrhythmias, valvular heart disease, heart disease in pregnancy, and a final segment on largely underrecognized issues in women, including peripheral arterial disease, cardio-oncology, and the current status of evidence-based medicine for the treatment of heart disease in women. Many of the chapters are written by leaders in the field of women’s cardiovascular health who have been instrumental in bringing attention to the sex-specific nature of heart disease pathophysiology and sex disparities that exist in cardiac care. It would be of great benefit to any practitioner to read this book cover to cover, but unfortunately time often dictates a more abbreviated approach to acquiring new knowledge. The following are particularly noteworthy chapters to be read if time precludes an extensive review of this topic. Chapter 3, by Sanne Peters and colleagues, provides a very well-articulated overview of the current literature on sex differences in conventional cardiovascular risk factors and their association with heart disease and stroke in women and men. Chapters 10 and 11 address the nontraditional, and often overlooked, risk factors of psychosocial stress and autoimmune disease, respectively, which can contribute to the development of cardiovascular disease in women. Dr Nanette Wenger and colleagues author the well-written and very comprehensive chapter on stable ischemic heart disease in women, expertly highlighting the sex-specific differences in treatment. Chapters 18 and 19 provide a thorough review of the literature on noninvasive stress testing in women with clinically relevant and useful guidance that would be an asset to any medical practitioner. The management of women with heart failure is expertly reviewed in Chapter 20 by Dr Ileana Pina and colleagues. This chapter incorporates supporting data from many contemporary trials, both completed and ongoing; however, a noticeable omission was the lack of emphasis on heart failure with preserved ejection fraction that is considerably more prevalent among women than men. Chapter 21 provides an interesting discussion about sex hormones, immunity, and myocarditis, and compliments the following chapter, a well-written overview on Takotsubo Cardiomyopathy. Dr Anne Curtis and Deepika Narasimha eloquently explore the sex-specific differences in cardiac electrophysiology in Chapter 23. Chapter 28 summarizes cardiac hemodynamics during pregnancy and the frequently encountered cardiac conditions in pregnant women including both preexisting and acquired heart disease; however, a discussion on spontaneous coronary artery dissection, a condition with increased incidence in the peripartum period, is noticeably absent. Dr Reema Chugh authored the chapter entitled, “Management of Heart Disease in Pregnancy: A Clinician’s Approach,” which provides extremely helpful clinical recommendations on a multitude of cardiac issues that can arise during pregnancy and emphasizes the importance of a multispecialty team to optimize the health of both mother and child during the peripartum period. Speculative statements occasionally punctuate the text, but likely reflect the lack of rigorous study data on sex-specific differences in certain areas of cardiovascular disease and treatment. Knowledge of heart disease in women is constantly evolving and data are emerging that female-specific risk factors, such as complications of pregnancy (preeclampsia, gestational diabetes, and pregnancy-induced hypertension), are predictors for the development of heart disease later in life. Greater emphasis on these nontraditional risk factors and a discussion of risk scores for women (eg, Reynolds risk score) would have further complimented the current content. This text was published after the most recent updates to the evidence-based guidelines on the management of hyperlipidemia and high blood pressure in adults (Eighth Joint National Committee). These new guidelines are referenced in Chapter 2, which discusses the prevention of heart disease in women, but unfortunately are not included in the dedicated chapters on Dyslipidemia in Women (Chapter 4) or Hypertension in Women (Chapter 7). Additionally, there is some redundancy, overlap, and, at times, even contradictions in the content, but this text largely reflects our contemporary understanding of heart disease in women and demonstrates that, although much has been learned, knowledge gaps in women’s cardiovascular health still remain and are in need of further study. The combination of expert contributions to Heart Disease in Women results in an indispensable resource for all medical professionals, but particularly those in cardiology, internal medicine, and obstetrics and gynecology. For the busy practitioner, this text can be used as a single point of reference for a spectrum of women’s cardiac issues ranging from anticoagulation management during pregnancy to the recommended diagnostic strategy","PeriodicalId":75674,"journal":{"name":"Cardiovascular clinics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"43","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular clinics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp/books/12562","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 43

Abstract

e5 Heart disease is the leading cause of death among women. In comparison with men, women have greater cardiovascular mortality, report more morbidity, and have greater reductions in quality of life. Furthermore, sex disparities in cardiovascular health exist among women of all ages, socioeconomic backgrounds, and racial subgroups, which likely reflect both lingering diagnostic and treatment disparities, and underlying biological sex differences, as well. For example, there is a largely female predominance of stress-induced (Takotsubo) cardiomyopathy after menopause, a greater occurrence of heart failure with preserved ejection fraction, particularly in elderly women, and a higher incidence of rheumatic mitral stenosis among women in developing countries. In addition, after 55 years of age, hypertension is more prevalent in women than in men, particularly in black women. Clinical outcomes also differ by sex. Women with atrial fibrillation have a higher risk of thromboembolic events in comparison with men, and, among individuals younger than 55 years of age, the rate of acute myocardial infarction in the past decade has declined in men, but not in women. As the importance and impact of cardiovascular disease in women is increasingly recognized, we are learning how heart disease is distinct between the sexes, both in its pathophysiology and in our ability to diagnose and treat women. To better understand and appreciate sex differences in cardiovascular disease, there needs to be a compilation of current knowledge and an accessible tool that increases awareness of these differences. Heart Disease in Women, by Drs Navin Nanda and Nurgul Keser, is that clinical tool and an excellent resource for all providers of women’s health. Heart Disease in Women brings greater awareness to sex-specific differences in heart disease and emphasizes the unique features of cardiovascular disease in women. The book consists of 34 chapters organized into 8 sections covering prevention and risk factors, coronary heart disease, noninvasive testing, heart failure and cardiomyopathies, arrhythmias, valvular heart disease, heart disease in pregnancy, and a final segment on largely underrecognized issues in women, including peripheral arterial disease, cardio-oncology, and the current status of evidence-based medicine for the treatment of heart disease in women. Many of the chapters are written by leaders in the field of women’s cardiovascular health who have been instrumental in bringing attention to the sex-specific nature of heart disease pathophysiology and sex disparities that exist in cardiac care. It would be of great benefit to any practitioner to read this book cover to cover, but unfortunately time often dictates a more abbreviated approach to acquiring new knowledge. The following are particularly noteworthy chapters to be read if time precludes an extensive review of this topic. Chapter 3, by Sanne Peters and colleagues, provides a very well-articulated overview of the current literature on sex differences in conventional cardiovascular risk factors and their association with heart disease and stroke in women and men. Chapters 10 and 11 address the nontraditional, and often overlooked, risk factors of psychosocial stress and autoimmune disease, respectively, which can contribute to the development of cardiovascular disease in women. Dr Nanette Wenger and colleagues author the well-written and very comprehensive chapter on stable ischemic heart disease in women, expertly highlighting the sex-specific differences in treatment. Chapters 18 and 19 provide a thorough review of the literature on noninvasive stress testing in women with clinically relevant and useful guidance that would be an asset to any medical practitioner. The management of women with heart failure is expertly reviewed in Chapter 20 by Dr Ileana Pina and colleagues. This chapter incorporates supporting data from many contemporary trials, both completed and ongoing; however, a noticeable omission was the lack of emphasis on heart failure with preserved ejection fraction that is considerably more prevalent among women than men. Chapter 21 provides an interesting discussion about sex hormones, immunity, and myocarditis, and compliments the following chapter, a well-written overview on Takotsubo Cardiomyopathy. Dr Anne Curtis and Deepika Narasimha eloquently explore the sex-specific differences in cardiac electrophysiology in Chapter 23. Chapter 28 summarizes cardiac hemodynamics during pregnancy and the frequently encountered cardiac conditions in pregnant women including both preexisting and acquired heart disease; however, a discussion on spontaneous coronary artery dissection, a condition with increased incidence in the peripartum period, is noticeably absent. Dr Reema Chugh authored the chapter entitled, “Management of Heart Disease in Pregnancy: A Clinician’s Approach,” which provides extremely helpful clinical recommendations on a multitude of cardiac issues that can arise during pregnancy and emphasizes the importance of a multispecialty team to optimize the health of both mother and child during the peripartum period. Speculative statements occasionally punctuate the text, but likely reflect the lack of rigorous study data on sex-specific differences in certain areas of cardiovascular disease and treatment. Knowledge of heart disease in women is constantly evolving and data are emerging that female-specific risk factors, such as complications of pregnancy (preeclampsia, gestational diabetes, and pregnancy-induced hypertension), are predictors for the development of heart disease later in life. Greater emphasis on these nontraditional risk factors and a discussion of risk scores for women (eg, Reynolds risk score) would have further complimented the current content. This text was published after the most recent updates to the evidence-based guidelines on the management of hyperlipidemia and high blood pressure in adults (Eighth Joint National Committee). These new guidelines are referenced in Chapter 2, which discusses the prevention of heart disease in women, but unfortunately are not included in the dedicated chapters on Dyslipidemia in Women (Chapter 4) or Hypertension in Women (Chapter 7). Additionally, there is some redundancy, overlap, and, at times, even contradictions in the content, but this text largely reflects our contemporary understanding of heart disease in women and demonstrates that, although much has been learned, knowledge gaps in women’s cardiovascular health still remain and are in need of further study. The combination of expert contributions to Heart Disease in Women results in an indispensable resource for all medical professionals, but particularly those in cardiology, internal medicine, and obstetrics and gynecology. For the busy practitioner, this text can be used as a single point of reference for a spectrum of women’s cardiac issues ranging from anticoagulation management during pregnancy to the recommended diagnostic strategy
女性心脏病
心脏病是妇女死亡的主要原因。与男性相比,女性心血管疾病死亡率更高,发病率更高,生活质量下降幅度更大。此外,心血管健康方面的性别差异存在于所有年龄、社会经济背景和种族亚组的女性中,这可能反映了挥之不去的诊断和治疗差异,以及潜在的生理性别差异。例如,绝经后压力诱发的(Takotsubo)心肌病在很大程度上以女性为主,保留射血分数的心力衰竭发生率更高,特别是在老年妇女中,发展中国家妇女风湿性二尖瓣狭窄的发生率更高。此外,55岁以后,高血压在女性中比男性更普遍,尤其是在黑人女性中。临床结果也因性别而异。与男性相比,患有房颤的女性血栓栓塞事件的风险更高,并且,在55岁以下的个体中,过去十年中男性急性心肌梗死的发生率有所下降,但女性没有。随着人们越来越认识到女性心血管疾病的重要性和影响,我们正在了解心脏病在病理生理学和我们诊断和治疗女性的能力方面在两性之间有何不同。为了更好地理解和认识心血管疾病的性别差异,需要汇编当前的知识和一种可获得的工具,以提高对这些差异的认识。Navin Nanda博士和Nurgul Keser博士的《妇女心脏病》是一种临床工具,也是所有妇女保健提供者的优秀资源。《妇女心脏病》提高了人们对心脏病性别差异的认识,并强调了妇女心血管疾病的独特特征。这本书由34章组成,分为8个部分,涵盖预防和危险因素,冠心病,无创检测,心力衰竭和心肌病,心律失常,心脏瓣膜病,怀孕期间的心脏病,最后一个部分是在很大程度上未被认识到的妇女问题,包括外周动脉疾病,心脏肿瘤学,以及妇女心脏病治疗的循证医学现状。许多章节是由妇女心血管健康领域的领导者撰写的,他们在引起人们对心脏病病理生理学的性别特异性和心脏护理中存在的性别差异的关注方面发挥了重要作用。对任何实践者来说,从头到尾地阅读这本书都是非常有益的,但不幸的是,时间往往要求我们采用更简短的方法来获取新知识。如果时间不允许对这个主题进行广泛的回顾,下面是特别值得注意的章节。第3章由Sanne Peters及其同事撰写,对目前关于传统心血管危险因素的性别差异及其与女性和男性心脏病和中风的关系的文献进行了非常清晰的概述。第10章和第11章分别讨论了往往被忽视的非传统风险因素,即社会心理压力和自身免疫性疾病,它们可能导致妇女心血管疾病的发展。纳内特·温格博士和他的同事们撰写了关于女性稳定性缺血性心脏病的一章,内容非常全面,写得很好,专业地强调了治疗中的性别差异。第18章和第19章对妇女无创压力测试的文献进行了全面的回顾,并提供了临床相关和有用的指导,这将是任何医疗从业者的财富。在第20章中,Ileana Pina博士及其同事对女性心力衰竭的管理进行了专业的回顾。本章包含来自许多当代试验的支持数据,包括已完成的和正在进行的;然而,一个值得注意的遗漏是缺乏对保留射血分数的心力衰竭的重视,这在女性中比男性更普遍。第21章对性激素、免疫和心肌炎进行了有趣的讨论,并补充了下一章对Takotsubo心肌病的良好概述。在第23章中,Anne Curtis博士和Deepika Narasimha博士雄辩地探讨了心脏电生理的性别差异。第28章总结了怀孕期间的心脏血流动力学和孕妇常见的心脏疾病,包括既存和获得性心脏病;然而,关于自发性冠状动脉剥离的讨论,这种情况在围产期发病率增加,显然是缺席的。 Reema Chugh博士撰写了题为“妊娠期心脏病管理:临床医生的方法”的章节,该章节针对妊娠期间可能出现的多种心脏问题提供了非常有用的临床建议,并强调了多专业团队在围产期优化母婴健康的重要性。推测性陈述偶尔会在正文中加标点,但这可能反映出在心血管疾病和治疗的某些领域,缺乏关于性别特异性差异的严格研究数据。对女性心脏病的认识在不断发展,有数据显示,女性特有的风险因素,如妊娠并发症(先兆子痫、妊娠糖尿病和妊娠高血压),是日后患心脏病的预测因素。更多地强调这些非传统的风险因素和对女性风险评分的讨论(例如,雷诺兹风险评分)将进一步补充当前的内容。本文是在《成人高脂血症和高血压管理循证指南》(第八届全国联合委员会)最新更新后发表的。这些新的指南在第2章中被引用,其中讨论了女性心脏病的预防,但不幸的是,没有包括在专门的章节中关于女性血脂异常(第4章)或女性高血压(第7章)。此外,有一些冗余,重叠,有时,甚至矛盾的内容,但这篇文章很大程度上反映了我们当代对女性心脏病的理解,并表明,尽管已经学到了很多东西,妇女心血管健康方面的知识差距仍然存在,需要进一步研究。《妇女心脏病》是所有医学专业人员,尤其是心脏病学、内科和妇产科专业人员不可或缺的资源。对于忙碌的从业者,这篇文章可以作为一个单一的参考点,为妇女的心脏问题的频谱范围从抗凝血管理在怀孕期间推荐的诊断策略
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信